SCHEMBL3759732

SCHEMBL3759732

CN(C(=O)O)C1CCN(C(=O)Cc2cccc(-c3cc(-c4c(N5CCOCC5)sc5c4CC(C)(C)CC5=O)ccn3)c2)CC1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
LMNA P02545 1/20 0.33
AOC3 Q16853 8/20 0.32
P2RY12 Q9H244 1/20 0.32
BUB1 O43683 1/20 0.32
SYK P43405 2/20 0.32
BRAF P15056 1/20 0.31
PIK3R1 P27986 1/20 0.31
PIK3CA P42336 2/20 0.31
MAPT P10636 2/20 0.31
PIK3CD O00329 1/20 0.31
PIK3CB P42338 1/20 0.31
PIK3CG P48736 1/20 0.31
HSD17B10 Q99714 2/20 0.31
KDM4E B2RXH2 1/20 0.31
GAA P10253 1/20 0.31
HPGD P15428 1/20 0.31
CASP1 P29466 1/20 0.31
CASP7 P55210 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3757747 0.93 ALDH1A1 (0.36) ALDH1A1SMN1; SMN2LMNAAOC3PIK3CA
SCHEMBL3767207 0.90 BRAF (0.39) ALDH1A1BUB1SYKBRAFPIK3R1
SCHEMBL3767336 0.90 POLB (0.35) ALDH1A1SMN1; SMN2AOC3P2RY12BUB1
SCHEMBL3765171 0.90 SYK (0.35) ALDH1A1SMN1; SMN2LMNABUB1SYK
SCHEMBL3765767 0.89 PIK3CA (0.36) ALDH1A1SMN1; SMN2AOC3P2RY12BUB1
SCHEMBL3764960 0.88 CTSK (0.34) ALDH1A1SMN1; SMN2LMNAAOC3BUB1
SCHEMBL16161748 0.88 PIK3CD (0.37) BUB1PIK3CD
SCHEMBL14080349 0.88 BUB1 (0.31) ALDH1A1SMN1; SMN2AOC3P2RY12BUB1
SCHEMBL3760091 0.88 CTSK (0.33) ALDH1A1SMN1; SMN2AOC3P2RY12BUB1
SCHEMBL3766079 0.87 SYK (0.34) BUB1SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA ALDH1A1 3061/4885SMN1; SMN2 1864/4885LMNA 4870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.